510(k) · Cleared
ClearedUroLift 2 ATC Advanced Tissue Control System
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Neotract, Inc. · PEW Implantable Transprostatic Tissue Retractor System
Cleared on Sep 22, 2023 as substantially equivalent to K201837 (Neotract, Inc., 2020) after a 30-day review. Its family tree reaches back 7 generations to 2013.
- Decided
- Sep 22, 2023
- Review
- 30 days
- Class
- Class II
- Product code
- PEW
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 7 generations to DEN130023 (2013). No later device cites it as a predicate yet.
- Root · 7 generations backDEN130023 Urolift SystemNeotract, Inc. · 2013
- 6 generations backK133281 Neotract Urolift SystemNeotract, Inc. · 2013
- 5 generations backK153584 NeoTract UroLift System UL500Neotract, Inc. · 2016
- 4 generations backK162345 UroLift System UL500, UroLift Delivery Handle, UroLift Implant…Neotract, Inc. · 2016
- 3 generations backK172359 UroLift System (UL500)Neotract, Inc. · 2017
- 2 generations backK173087 UroLift System (UL400 and UL500)Neotract, Inc. · 2017 · Recalled
- 1 generation backK201837 UroLift 2 System (formerly UL500), UroLift 2 Delivery Handle…Neotract, Inc. · 2020
- This deviceK232558 UroLift 2 ATC Advanced Tissue Control SystemNeotract, Inc. · 2023
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −7 | DEN130023 | Urolift System | Neotract, Inc. | 2013 | — |
| −6 | K133281 | Neotract Urolift System | Neotract, Inc. | 2013 | — |
| −5 | K153584 | NeoTract UroLift System UL500 | Neotract, Inc. | 2016 | — |
| −4 | K162345 | UroLift System UL500, UroLift Delivery Handle, UroLift Implant Cartiridge | Neotract, Inc. | 2016 | — |
| −3 | K172359 | UroLift System (UL500) | Neotract, Inc. | 2017 | — |
| −2 | K173087 | UroLift System (UL400 and UL500) | Neotract, Inc. | 2017 | 1 |
| −1 | K201837 | UroLift 2 System (formerly UL500), UroLift 2 Delivery Handle, UroLift 2… | Neotract, Inc. | 2020 | — |
| 0 (this device) | K232558 | UroLift 2 ATC Advanced Tissue Control System | Neotract, Inc. | 2023 | — |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in PEW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new PEW device
- #1 K201837 UroLift 2 System (formerly UL500), UroLift 2…score 4.3 · 6 generations · no Class I recall
- #2 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K201837 | UroLift 2 System (formerly UL500), UroLift 2 Delivery Handle, UroLift 2 Implant CartridgeSummary page 4…logy Devices (DHT3B) 03.5 DEVICE DESCRIPTION The UroLift 2 ATC Advanced Tissue Control System is a modification of the UroLift 2 System (last cleared in K201837). The primary difference is the addition of a wing component on the distal tip of the UroLift 2 ATC Advanced Tissue Contro… | 2020 |
| † | K200441 | UroLift Advanced Tissue Control (ATC) System | 2020 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 10 years and passes through 1 company; a new generation was cleared every 11 months on median.
- 1 of the 7 ancestors has a recall of any class.
How does its category compare?
All PEW devicesPEW Implantable Transprostatic Tissue Retractor System: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.
FDA decisions per year · PEW
1in 2023
2026 to Oct 25, outlined.
Median 510(k) review, days · PEW
Too few PEW 510(k)s in any year since 2007 to give a median.
Recalls per year · PEW
1in 2018
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · PEW
69in 2025
MAUDE reports naming product code PEW, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 2 | — | 0 | 1 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 6 |
| 2016 | 2 | — | 0 | 8 |
| 2017 | 2 | — | 0 | 8 |
| 2018 | 0 | — | 1 | 17 |
| 2019 | 2 | — | 0 | 47 |
| 2020 | 2 | — | 0 | 65 |
| 2021 | 0 | — | 0 | 50 |
| 2022 | 0 | — | 0 | 55 |
| 2023 | 1 | — | 0 | 52 |
| 2024 | 0 | — | 0 | 37 |
| 2025 | 0 | — | 0 | 69 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The UroLift System is indicated for the treatment of symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH), including lateral and median lobe hyperplasia, in men 45 years of age or older.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K232558 · printed Nov 6, 2026
Cite this page
510(k) Report. “K232558: UroLift 2 ATC Advanced Tissue Control System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K232558
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026